Work

PARP inhibition as frontline therapy in ovarian cancer.

Year: 2020

Type: article

Source: PubMed

Authors: Kathleen N Moore, Bhavana Pothuri, Bradley Monk, Robert L Coleman

Institutions: OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University, Creighton University, The US Oncology Network, University of Arizona College of Medicine- Phoenix

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3090680135

FWCI: 0.594

Cites:

Cited by: 8

Related to: 10